Cognitive Remediation in ADHD Children : Comparison Between Three Therapeutic Strategies : Cognitive Remediation With a Virtual Classroom Software and Methylphenidate and Supportive Psychotherapy

• Status: Completed
• Trial end date: 2016-04-27
• Target enrollment: 0
• Participant gender: All

Summary

The Attention Deficit Disorder with or without Hyperactivity (ADHD) is one of the most frequently found disorder in children. It is characterized by a triad of symptoms involving attention deficit, hyperactivity and impulsivity and having an impact on the functioning of the subject especially in terms of learning.

Currently, main interventions to treat ADHD in children are stimulant medication or supportive psychotherapy. Data from recent studies highlight the use of stimulant drugs (amphetamine derivatives such as methylphenidate) to treat the core symptoms of ADHD children. These drugs are generally effective but their nature (psychostimulants) and adverse effects they cause (appetite suppression, sleep disturbances, headaches, motor tics, abdominal pain, irritability, nausea and fatigue) encourage the development of new therapeutic approaches. The use of supportive psychotherapy alone would have limited effect on symptoms of children with ADHD. Our aim is to test the use a cognitive remediation program using a virtual classroom in children suffering from ADHD.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Bordeaux
• Collaborator: Fondation Caisse d'Epargne
• Treatments: Methylphenidate

Criteria

Inclusion Criteria:

• Patient, male or female, aged 7 to 11 years,

• Responding to current diagnostic criteria for ADHD according to DSM IV-TR (Diagnostic and Statistical Manual of Mental Disorders),

• Presenting a total score on the ADHD-RS (ADHD Rating Scale)> 28 (before treatment),

• Schooled in conventional class,

• Presenting a WISC (Wechsler Intelligence Scale for Children) IV total score> 80 (done before or in follow-up),

• Registered to social security,

• Legal represent has given informed consent to participate in the study.

Exclusion Criteria:

• Uncorrected perceptual disorder,

• Patient treated by psychostimulant,

• Patient under supportive psychotherapy,

• Patient treated by methylphenidate,

• Subjects with a pervasive developmental disorder, psychotic disorder, characterized major depressive disorder,

• Subjects who participated in research in the last 3 months,

• Subjects suffering from: glaucoma, hyperthyroidism, thyrotoxicosis, heart diseases (high blood pressure, congestive heart failure, etc…), cerebrovascular disorders,

• Subjects with no deficit in the virtual classroom: having a total number of hit superior to 80 and a number of commissions inferior to 21.